Analyzing the roles of multi-functional proteins in cells: The case of arrestins and GRKs

Critical Reviews in Biochemistry and Molecular Biology

Volumn 50, Issue 5, 2015, Pages 440-452

  Gurevich, Vsevolod V ^a   Gurevich, Eugenia V ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Arrestin; functional bias; GPCR; GRK; knockdown; knockout; overexpression; signaling

Indexed keywords

CLATHRIN; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; PHOSPHODIESTERASE IV; RETINA S ANTIGEN; LIGAND; MUTANT PROTEIN; RECOMBINANT PROTEIN;

CELL FUNCTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; REVIEW; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMISTRY; ENZYME ACTIVATION; GENE INACTIVATION; GENE SILENCING; GENETICS; METABOLISM; MOLECULAR MODEL; PROTEIN CONFORMATION; SIGNAL TRANSDUCTION;

ANIMALS; ARRESTINS; ENZYME ACTIVATION; G-PROTEIN-COUPLED RECEPTOR KINASES; GENE KNOCKDOWN TECHNIQUES; GENE KNOCKOUT TECHNIQUES; HUMANS; LIGANDS; MODELS, MOLECULAR; MUTANT PROTEINS; PROTEIN CONFORMATION; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION;

EID: 84944073554     PISSN: 10409238     EISSN: 15497798     Source Type: Journal    
DOI: 10.3109/10409238.2015.1067185     Document Type: Review

References (133)

1. Ahmed MR, Berthet A, Bychkov E, et al. (2010). Lentiviral overexpression of GRK6 alleviates L-dopa-induced dyskinesia in experimental Parkinson's disease. Sci Transl Med 2: 28ra28
2. Ahmed MR, Bychkov E, Li L, et al. (2015). GRK3 suppresses L-DOPA-induced dyskinesia in the rat model of Parkinsons disease via its RGS homology domain. Sci Rep 5: 10920
3. Ahmed MR, Zhan X, Song X, et al. (2011). Ubiquitin ligase parkin promotes Mdm2-arrestin interaction but inhibits arrestin ubiquitination. Biochemistry 50: 3749-63
4. Akhter SA, Eckhart AD, Rockman HA, et al. (1999). In vivo inhibition of elevated myocardial beta-adrenergic receptor kinase activity in hybrid transgenic mice restores normal beta-adrenergic signaling and function. Circulation 100: 648-53
5. Attramadal H, Arriza JL, Aoki C, et al. (1992). Beta-arrestin2, a novel member of the arrestin/beta-arrestin gene family. J Biol Chem 267: 17882-90
6. Baillie GS, Adams DR, Bhari N, et al. (2007). Mapping binding sites for the PDE4D5 cAMP-specific phosphodiesterase to the N- and C-domains of beta-arrestin using spot-immobilized peptide arrays. Biochem J 404: 71-80
7. Benovic JL, DeBlasi A, Stone WC, et al. (1989). Beta-adrenergic receptor kinase: primary structure delineates a multigene family. Science 246: 235-40
8. Bhandari D, Trejo J, Benovic JL, Marchese A. (2007). Arrestin-2 interacts with the ubiquitin-protein isopeptide ligase atrophin-interacting protein 4 and mediates endosomal sorting of the chemokine receptor CXCR4. J Biol Chem 282: 36971-9
9. Bockaert J, Pin JP. (1999). Molecular tinkering of G protein-coupled receptors: an evolutionary success. EMBO J 18: 1723-9
10. Breitman M, Kook S, Gimenez LE, et al. (2012). Silent scaffolds: inhibition of c-Jun N-terminal kinase 3 activity in the cell by a dominant-negative arrestin-3 mutant. J Biol Chem 287: 19653-64
11. Bruchas MR, Macey TA, Lowe JD, Chavkin C. (2006). Kappa opioid receptor activation of p38 MAPK is GRK3- and arrestin-dependent in neurons and astrocytes. J Biol Chem 281: 18081-9
12. Caplen NJ. (2003). RNAi as a gene therapy approach. Expert Opin Biol Ther 3: 575-86
13. Carman CV, Benovic JL. (1998). G-protein-coupled receptors: turn-ons and turn-offs. Curr Opin Neurobiol 8: 335-44
14. Carman CV, Parent JL, Day PW, et al. (1999). Selective regulation of Galpha(q/11) by an RGS domain in the G protein-coupled receptor kinase, GRK2. J Biol Chem 274: 34483-92
15. Carter JM, Gurevich VV, Prossnitz ER, Engen JR. (2005). Conformational differences between arrestin2 and pre-activated mutants as revealed by hydrogen exchange mass spectrometry. J Mol Biol 351: 865-78
16. Celver J, Vishnivetskiy SA, Chavkin C, Gurevich VV. (2002). Conservation of the phosphate-sensitive elements in the arrestin family of proteins. J Biol Chem 277: 9043-8
17. Cleghorn WM, Branch KM, Kook S, et al. (2015). Arrestins regulate cell spreading and motility via focal adhesion dynamics. Mol Biol Cell 26: 622-35
18. Cleghorn WM, Tsakem EL, Song X, et al. (2011). Progressive reduction of its expression in rods reveals two pools of arrestin-1 in the outer segment with different roles in photoresponse recovery. PLoS One 6: e22797
19. Coffa S, Breitman M, Hanson SM, et al. (2011a). The effect of arrestin conformation on the recruitment of c-Raf1, MEK1, and ERK1/2 activation. PLoS One 6: e28723
20. Coffa S, Breitman M, Spiller BW, Gurevich VV. (2011b). A single mutation in arrestin-2 prevents ERK1/2 activation by reducing c-Raf1 binding. Biochemistry 50: 6951-8
21. Cookson MR. (2010). The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease. Nat Rev Neurosci 11: 791-7
22. Daaka Y, Pitcher JA, Richardson M, et al. (1997). Receptor and G betagamma isoform-specific interactions with G protein-coupled receptor kinases. Proc Natl Acad Sci USA 94: 2180-5
23. Danial NN, Korsmeyer SJ. (2004). Cell death: critical control points. Cell 116: 205-19
24. Day PW, Carman CV, Sterne-Marr R, et al. (2003). Differential interaction of GRK2 with members of the G alpha q family. Biochemistry 42: 9176-84
25. Day PW, Wedegaertner PB, Benovic JL. (2004). Analysis of G-protein-coupled receptor kinase RGS homology domains. Methods Enzymol 390: 295-310
26. DeFea KA, Vaughn ZD, O'Bryan EM, et al. (2000). The proliferative and antiapoptotic effects of substance P are facilitated by formation of a beta -arrestin-dependent scaffolding complex. Proc Natl Acad Sci USA 97: 11086-91
27. DeWire SM, Ahn S, Lefkowitz RJ, Shenoy SK. (2007). Beta-arrestins and cell signaling. Annu Rev Physiol 69: 483-510
28. Farrer M, Chan P, Chen R, et al. (2001). Lewy bodies and parkinsonism in families with parkin mutations. Ann Neurol 50: 293-300
29. Feil S, Valtcheva N, Feil R. (2009). Inducible Cre mice. Methods Mol Biol 530: 343-63
30. Fuchs S, Nakazawa M, Maw M, et al. (1995). A homozygous 1-base pair deletion in the arrestin gene is a frequent cause of Oguchi disease in Japanese. Nat Genet 10: 360-2
31. Gibbs CS, Zoller MJ. (1991). Rational scanning mutagenesis of a protein kinase identifies functional regions involved in catalysis and substrate interactions. J Biol Chem 266: 8923-31
32. Gimenez LE, Babilon S, Wanka L, et al. (2014). Mutations in arrestin-3 differentially affect binding to neuropeptide Y receptor subtypes. Cell Signal 26: 1523-31
33. Gimenez LE, Kook S, Vishnivetskiy SA, et al. (2012a). Role of receptor-attached phosphates in binding of visual and non-visual arrestins to G protein-coupled receptors. J Biol Chem 287: 9028-40
34. Gimenez LE, Vishnivetskiy SA, Baameur F, Gurevich VV. (2012b). Manipulation of very few receptor discriminator residues greatly enhances receptor specificity of non-visual arrestins. J Biol Chem 287: 29495-505
35. Goodman OB Jr, Krupnick JG, Santini F, et al. (1996). Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor. Nature 383: 447-50
36. Gray-Keller MP, Detwiler PB, Benovic JL, Gurevich VV. (1997). Arrestin with a single amino acid sustitution quenches light-activated rhodopsin in a phosphorylation independent fasion. Biochemistry 36: 7058-63
37. Gurevich EV, Ahmed MR, Carl YT. (2014). In vivo gene silencing by virally delivered microRNA. In: Brambilla R., ed. Viral vector approaches in neurobiology and brain diseases. New York: Humana Press, 245-68
38. Gurevich EV, Gurevich VV. (2006a). Arrestins are ubiquitous regulators of cellular signaling pathways. Genome Biol 7: 236
39. Gurevich EV, Gurevich VV. (2010). Dopamine receptors and the treatment of Parkinsons disease. In: Neve K., ed. Dopamine receptors. New York: Humana Press, 525-84
40. Gurevich EV, Tesmer JJ, Mushegian A, Gurevich VV. (2012). G protein-coupled receptor kinases: more than just kinases and not only for GPCRs. Pharmacol Ther 133: 40-69
41. Gurevich VV. (1998). The selectivity of visual arrestin for light-activated phosphorhodopsin is controlled by multiple nonredundant mechanisms. J Biol Chem 273: 15501-6
42. Gurevich VV, Benovic JL. (1995). Visual arrestin binding to rhodopsin: diverse functional roles of positively charged residues within the phosphorylation-recignition region of arrestin. J Biol Chem 270: 6010-16
43. Gurevich VV, Benovic JL. (1997). Mechanism of phosphorylation-recognition by visual arrestin and the transition of arrestin into a high affinity binding state. Mol Pharmacol 51: 161-9
44. Gurevich VV, Dion SB, Onorato JJ, et al. (1995). Arrestin interaction with G protein-coupled receptors. Direct binding studies of wild type and mutant arrestins with rhodopsin, b2-adrenergic, and m2 muscarinic cholinergic receptors. J Biol Chem 270: 720-31
45. Gurevich VV, Gurevich EV. (2004). The molecular acrobatics of arrestin activation. Trends Pharmacol Sci 25: 59-112
46. Gurevich VV, Gurevich EV. (2006b). The structural basis of arrestin-mediated regulation of G protein-coupled receptors. Pharm Ther 110: 465-502
47. Gurevich VV, Gurevich EV. (2012). Synthetic biology with surgical precision: targeted reengineering of signaling proteins. Cell Signal 24: 1899-908
48. Gurevich VV, Gurevich EV. (2014). Extensive shape shifting underlies functional versatility of arrestins. Curr Opin Cell Biol 27: 1-9
49. Gurevich VV, Hanson SM, Song X, et al. (2011). The functional cycle of visual arrestins in photoreceptor cells. Prog Retin Eye Res 30: 405-30
50. Gurevich VV, Pals-Rylaarsdam R, Benovic JL, et al. (1997). Agonist-receptor-arrestin, an alternative ternary complex with high agonist affinity. J Biol Chem 272: 28849-52
51. Gurevich VV, Richardson RM, Kim CM, et al. (1993). Binding of wild type and chimeric arrestins to the m2 muscarinic cholinergic receptor. J Biol Chem 268: 16879-82
52. Han M, Gurevich VV, Vishnivetskiy SA, et al. (2001). Crystal structure of beta-arrestin at 1.9 A: possible mechanism of receptor binding and membrane translocation. Structure 9: 869-80
53. Han SO, Kommaddi RP, Shenoy SK. (2013). Distinct roles for β-arrestin2 and arrestin-domain-containing proteins in β2 adrenergic receptor trafficking. EMBO Rep 14: 164-71
54. Hanson SM, Francis DJ, Vishnivetskiy SA, et al. (2006a). Visual arrestin binding to microtubules involves a distinct conformational change. J Biol Chem 281: 9765-72
55. Hanson SM, Francis DJ, Vishnivetskiy SA, et al. (2006b). Differential interaction of spin-labeled arrestin with inactive and active phosphorhodopsin. Proc Natl Acad Sci USA 103: 4900-5
56. Hanson SM, Gurevich VV. (2006). The differential engagement of arrestin surface charges by the various functional forms of the receptor. J Biol Chem 281: 3458-62
57. Hirsch JA, Schubert C, Gurevich VV, Sigler PB. (1999). The 2.8 A crystal structure of visual arrestin: a model for arrestin's regulation. Cell 97: 257-69
58. Hüttemann M, Pecina P, Rainbolt M, et al. (2011). The multiple functions of cytochrome c and their regulation in life and death decisions of the mammalian cell: From respiration to apoptosis. Mitochondrion 11: 369-81
59. Imamura T, Huang J, Dalle S, et al. (2001). beta-Arrestin-mediated recruitment of the Src family kinase Yes mediates endothelin-1-stimulated glucose transport. J Biol Chem 276: 43663-7
60. Jonchere V, Bennett D. (2013). Validating RNAi phenotypes in Drosophila using a synthetic RNAi-resistant transgene. PLoS One 8: e70489
61. Khan NL, Scherfler C, Graham E, et al. (2005). Dopaminergic dysfunction in unrelated, asymptomatic carriers of a single parkin mutation. Neurology 64: 134-6
62. Kim M, Hanson SM, Vishnivetskiy SA, et al. (2011). Robust self-association is a common feature of mammalian visual arrestin-1. Biochemistry 50: 2235-42
63. Kim YM, Benovic JL. (2002). Differential roles of arrestin-2 interaction with clathrin and adaptor protein 2 in G protein-coupled receptor trafficking. J Biol Chem 277: 30760-8
64. Kitada T, Asakawa S, Hattori N, et al. (1998). Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392: 544-5
65. Kohout TA, Lin FS, Perry SJ, et al. (2001). beta-Arrestin 1 and 2 differentially regulate heptahelical receptor signaling and trafficking. Proc Nat Acad Sci USA 98: 1601-6
66. Kong G, Penn R, Benovic JL. (1994). A beta-adrenergic receptor kinase dominant negative mutant attenuates desensitization of the beta 2-adrenergic receptor. J Biol Chem 269: 13084-7
67. Kook S, Zhan X, Kaoud TS, et al. (2013). Arrestin-3 binds JNK1α1 and JNK2α2 and facilitates the activation of these ubiquitous JNK isoforms in cells via scaffolding. J Biol Chem 288: 37332-42
68. Kovoor A, Celver J, Abdryashitov RI, et al. (1999). Targeted construction of phosphorylation-independent b-arrestin mutants with constitutive activity in cells. J Biol Chem 274: 6831-4
69. Krupnick JG, Goodman OB Jr, Keen JH, Benovic JL. (1997a). Arrestin/clathrin interaction. Localization of the clathrin binding domain of nonvisual arrestins to the carboxy terminus. J Biol Chem 272: 15011-16
70. Krupnick JG, Gurevich VV, Benovic JL. (1997b). Mechanism of quenching of phototransduction. Binding competition between arrestin and transducin for phosphorhodopsin. J Biol Chem 272: 18125-31
71. Kuhn H, Hall SW, Wilden U. (1984). Light-induced binding of 48-kDa protein to photoreceptor membranes is highly enhanced by phosphorylation of rhodopsin. FEBS Lett 176: 473-8
72. Laporte SA, Oakley RH, Zhang J, et al. (1999). The 2-adrenergic receptor/arrestin complex recruits the clathrin adaptor AP-2 during endocytosis. Proc Nat Acad Sci USA 96: 3712-17
73. Lewandoski M. (2001). Conditional control of gene expression in the mouse. Nat Rev Genet 2: 743-55
74. Lin FT, Krueger KM, Kendall HE, et al. (1997). Clathrin-mediated endocytosis of the beta-adrenergic receptor is regulated by phosphorylation/dephosphorylation of beta-arrestin1. J Biol Chem 272: 31051-7
75. Lohse MJ, Andexinger S, Pitcher J, et al. (1992). Receptor-specific desensitization with purified proteins. Kinase dependence and receptor specificity of beta-arrestin and arrestin in the beta 2-adrenergic receptor and rhodopsin systems. J Biol Chem 267: 8558-64
76. Lohse MJ, Benovic JL, Codina J, et al. (1990). beta-Arrestin: a protein that regulates beta-adrenergic receptor function. Science 248: 1547-50
77. Lücking CB, Dürr A, Bonifati V, et al. (2000). Association between early-onset Parkinson's disease and mutations in the Parkin gene. N Engl J Med 342: 1560-7
78. Luttrell LM, Ferguson SS, Daaka Y, et al. (1999). Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. Science 283: 655-61
79. Luttrell LM, Roudabush FL, Choy EW, et al. (2001). Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds. Proc Natl Acad Sci USA 98: 2449-54
80. Manteniotis S, Lehmann R, Flegel C, et al. (2013). Comprehensive RNA-Seq expression analysis of sensory ganglia with a focus on ion channels and GPCRs in trigeminal ganglia. PLoS One 8: e79523
81. McDonald PH, Chow CW, Miller WE, et al. (2000). Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3. Science 290: 1574-7
82. McDonald PH, Cote NL, Lin FT, et al. (1999). Identification of NSF as a beta-arrestin1-binding protein. Implications for beta2-adrenergic receptor regulation. J Biol Chem 274: 10677-80
83. Meng D, Lynch MJ, Huston E, et al. (2009). MEK1 binds directly to betaarrestin1, influencing both its phosphorylation by ERK and the timing of its isoprenaline-stimulated internalization. J Biol Chem 284: 11425-35
84. Moaven H, Koike Y, Jao CC, et al. (2013). Visual arrestin interaction with clathrin adaptor AP-2 regulates photoreceptor survival in the vertebrate retina. Proc Natl Acad Sci USA 110: 9463-8
85. Nabhan JF, Pan H, Lu Q. (2010). Arrestin domain-containing protein 3 recruits the NEDD4 E3 ligase to mediate ubiquitination of the beta2-adrenergic receptor. EMBO Rep 11: 605-11
86. Nair KS, Hanson SM, Kennedy MJ, et al. (2004). Direct binding of visual arrestin to microtubules determines the differential subcellular localization of its splice variants in rod photoreceptors. J Biol Chem 279: 41240-8
87. Nair KS, Hanson SM, Mendez A, et al. (2005). Light-dependent redistribution of arrestin in vertebrate rods is an energy-independent process governed by protein-protein interactions. Neuron 46: 555-67
88. Nakajima K, Wess J. (2012). Design and functional characterization of a novel, arrestin-biased designer G protein-coupled receptor. Mol Pharmacol 82: 575-82
89. Nelson CD, Perry SJ, Regier DS, et al. (2007). Targeting of diacylglycerol degradation to M1 muscarinic receptors by beta-arrestins. Science 315: 663-6
90. Ohno S, Konno Y, Akita Y, et al. (1990). A point mutation at the putative ATP-binding site of protein kinase C alpha abolishes the kinase activity and renders it down-regulation-insensitive. A molecular link between autophosphorylation and down-regulation. J Biol Chem 265: 6296-300
91. Pan L, Gurevich EV, Gurevich VV. (2003). The nature of the arrestin x receptor complex determines the ultimate fate of the internalized receptor. J Biol Chem 278: 11623-32
92. Perry SJ, Baillie GS, Kohout TA, et al. (2002). Targeting of cyclic AMP degradation to beta 2-adrenergic receptors by beta-arrestins. Science 298: 834-6
93. Peterson SM, Pack TF, Wilkins AD, et al. (2015). Elucidation of G-protein and β-arrestin functional selectivity at the dopamine D2 receptor. Proc Natl Acad Sci USA 112: 7097-102
94. Pramstaller PP, Scaravilli F, Eskelson C, et al. (2005). Lewy body Parkinson's disease in a large pedigree with 77 Parkin mutation carriers. Ann Neurol 58: 411-22
95. Pronin A, Levay K, Velmeshev D, et al. (2014). Expression of olfactory signaling genes in the eye. PLoS One 9: e96435
96. Raveh A, Cooper A, Guy-David L, Reuveny E. (2010). Nonenzymatic rapid control of GIRK channel function by a G protein-coupled receptor kinase. Cell 143: 750-60
97. Restagno G, Maghtheh M, Bhattacharya S, et al. (1993). A large deletion at the 3' end of the rhodopsin gene in an Italian family with a diffuse form of autosomal dominant retinitis pigmentosa. Hum Mol Genet 2: 207-8
98. Roman G, He J, Davis RL. (2000). kurtz, a novel nonvisual arrestin, is an essential neural gene in Drosophila. Genetics 155: 1281-95
99. Salazar NC, Vallejos X, Siryk A, et al. (2013). GRK2 blockade with βARKct is essential for cardiac β2-adrenergic receptor signaling towards increased contractility. Cell Commun Signal 11: 64
100. Schoneberg T, Schulz A, Biebermann H, et al. (2004). Mutant G-protein-coupled receptors as a cause of human diseases. Pharmacol Ther 104: 173-206
101. Seo J, Tsakem EL, Breitman M, Gurevich VV. (2011). Identification of arrestin-3-specific residues necessary for JNK3 activation. J Biol Chem 286: 27894-901
102. Shaw AS, Kornev AP, Hu J, et al. (2014). Kinases and pseudokinases: lessons from RAF. Mol Cell Biol 34: 1538-46
103. Shenoy SK, McDonald PH, Kohout TA, Lefkowitz RJ. (2001). Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin. Science 294: 1307-13
104. Shenoy SK, Modi AS, Shukla AK, et al. (2009). Beta-arrestin-dependent signaling and trafficking of 7-transmembrane receptors is reciprocally regulated by the deubiquitinase USP33 and the E3 ligase Mdm2. Proc Natl Acad Sci USA 106: 6650-5
105. Shenoy SK, Xiao K, Venkataramanan V, et al. (2008). Nedd4 mediates agonist-dependent ubiquitination, lysosomal targeting, and degradation of the beta2-adrenergic receptor. J Biol Chem 283: 22166-76
106. Song X, Coffa S, Fu H, Gurevich VV. (2009a). How does arrestin assemble MAPKs into a signaling complex? J Biol Chem 284: 685-95
107. Song X, Seo J, Baameur F, et al. (2013). Rapid degeneration of rod photoreceptors expressing self-association-deficient arrestin-1 mutant. Cell Signal 25: 2613-24
108. Song X, Vishnivetskiy SA, Gross OP, et al. (2009b). Enhanced arrestin facilitates recovery and protects rod photoreceptors deficient in rhodopsin phosphorylation. Curr Biol 19: 700-5
109. Song X, Vishnivetskiy SA, Seo J, et al. (2011). Arrestin-1 expression in rods: balancing functional performance and photoreceptor health. Neuroscience 174: 37-49
110. Sriram SR, Li X, Ko HS, et al. (2005). Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin. Hum Mol Genet 14: 2571-86
111. Sterne-Marr R, Dhami GK, Tesmer JJ, Ferguson SS. (2004). Characterization of GRK2 RH domain-dependent regulation of GPCR coupling to heterotrimeric G proteins. Methods Enzymol 390: 310-36
112. Sterne-Marr R, Gurevich VV, Goldsmith P, et al. (1993). Polypeptide variants of beta-arrestin and arrestin3. J Biol Chem 268: 15640-8
113. Sterne-Marr R, Tesmer JJ, Day PW, et al. (2003). G protein-coupled receptor Kinase 2/G alpha q/11 interaction. A novel surface on a regulator of G protein signaling homology domain for binding G alpha subunits. J Biol Chem 278: 6050-8
114. Stoy H, Gurevich VV. (2015). How genetic errors in GPCRs affect their function: possible therapeutic strategies. Genes Dis 2: 108-32
115. Sun F, Zhou Q, Pang X, et al. (2013). Revealing various coupling of electron transfer and proton pumping in mitochondrial respiratory chain. Curr Opin Struct Biol 23: 526-38
116. Taylor SS, Shaw A, Hu J, et al. (2013). Pseudokinases from a structural perspective. Biochem Soc Trans 41: 981-6
117. Violin JD, Crombie AL, Soergel DG, Lark MW. (2014). Biased ligands at G-protein-coupled receptors: promise and progress. Trends Pharmacol Sci 35: 308-16
118. Violin JD, DiPilato LM, Yildirim N, et al. (2008). beta2-adrenergic receptor signaling and desensitization elucidated by quantitative modeling of real time cAMP dynamics. J Biol Chem 283: 2949-61
119. Vishnivetskiy SA, Chen Q, Palazzo MC, et al. (2013). Engineering visual arrestin-1 with special functional characteristics. J Biol Chem 288: 11741-50
120. Vishnivetskiy SA, Francis DJ, Van Eps N, et al. (2010). The role of arrestin alpha-helix I in receptor binding. J Mol Biol 395: 42-54
121. Vishnivetskiy SA, Gimenez LE, Francis DJ, et al. (2011). Few residues within an extensive binding interface drive receptor interaction and determine the specificity of arrestin proteins. J Biol Chem 286: 24288-99
122. Vishnivetskiy SA, Hosey MM, Benovic JL, Gurevich VV. (2004). Mapping the arrestin-receptor interface: structural elements responsible for receptor specificity of arrestin proteins. J Biol Chem 279: 1262-8
123. Vishnivetskiy SA, Schubert C, Climaco GC, et al. (2000). An additional phosphate-binding element in arrestin molecule: implications for the mechanism of arrestin activation. J Biol Chem 275: 41049-57
124. Wang C, Tan JM, Ho MW, et al. (2005). Alterations in the solubility and intracellular localization of parkin by several familial Parkinson's disease-linked point mutations. J Neurochem 93: 422-31
125. Wilden U. (1995). Duration and amplitude of the light-induced cGMP hydrolysis in vertebrate photoreceptors are regulated by multiple phosphorylation of rhodopsin and by arrestin binding. Biochemistry 34: 1446-54
126. Wilden U, Hall SW, Kühn H. (1986). Phosphodiesterase activation by photoexcited rhodopsin is quenched when rhodopsin is phosphorylated and binds the intrinsic 48-kDa protein of rod outer segments. Proc Natl Acad Sci USA 83: 1174-8
127. Xiao K, McClatchy DB, Shukla AK, et al. (2007). Functional specialization of beta-arrestin interactions revealed by proteomic analysis. Proc Natl Acad Sci USA 104: 12011-16
128. Xu J, Dodd RL, Makino CL, et al. (1997). Prolonged photoresponses in transgenic mouse rods lacking arrestin. Nature 389: 505-9
129. Yu Y, Ping J, Chen H, et al. (2010). A comparative analysis of liver transcriptome suggests divergent liver function among human, mouse and rat. Genomics 96: 281-9
130. Zhan X, Gimenez LE, Gurevich VV, Spiller BW. (2011). Crystal structure of arrestin-3 reveals the basis of the difference in receptor binding between two non-visual arrestins. J Mol Biol 406: 467-78
131. Zhan X, Kaoud TS, Kook S, et al. (2013). JNK3 binding to arrestin-3 differentially affects the recruitment of upstream MAP kinase kinases. J Biol Chem 288: 28535-47
132. Zhan X, Perez A, Gimenez LE, et al. (2014). Arrestin-3 binds the MAP kinase JNK3α2 via multiple sites on both domains. Cell Signal 26: 766-76
133. Zhuo Y, Vishnivetskiy SA, Zhan X, et al. (2014). Identification of receptor binding-induced conformational changes in non-visual arrestins. J Biol Chem 289: 20991-1002